Staging, surveillance, and evaluation of response to therapy in renal cell carcinoma: role of MDCT.
Renal cell carcinoma is the most common malignant renal tumor in the adults. Significant advances have been made in the management of localized and advanced renal cell carcinoma. Surgery is the standard of care and accurate pre-operative staging based on imaging is critical in guiding appropriate patient management. Besides staging, imaging plays a key role in the post-operative surveillance and evaluation of response to systemic therapies. Both CT and MR are useful in the staging and follow up of renal cell carcinoma, but CT is more commonly used due to its lower costs and wider availability. In this article, we discuss and illustrate the role of multi-detector CT in pre-operative staging, post-operative surveillance, and evaluation of response to systemic therapy in renal cell carcinoma.
Dhakshinamoorthy
D
Ganeshan
Ajay
A
Morani
Harshad
H
Ladha
Tharakeshwar
T
Bathala
Hyunseon
H
Kang
Shiva
S
Gupta
Neeraj
N
Lalwani
Vikas
V
Kundra
D002292:Carcinoma, Renal Cell / Q000000981:diagnostic imaging* / Q000473:pathology* / Q000601:surgery; D006801:Humans; D007680:Kidney Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology* / Q000601:surgery / Q000628:therapy; D061330:Multidetector Computed Tomography; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D009392:Nephrectomy; D011159:Population Surveillance; D012082:Renal Veins / Q000473:pathology; D012680:Sensitivity and Specificity; D016896:Treatment Outcome; D014682:Vena Cava, Inferior / Q000473:pathology